Thomas Kassberg
Vermogen: 9 M $ op 30-06-2026
Vermogen: 9 M $ op 30-06-2026
Thomas Richard Kassberg was the founder of Plexxikon, Inc., founded in 2000, where the title held was Vice President-Business & Corporate Development from 2000 to 2004.
The current job is Director at Passage Bio, Inc. starting in 2024.
Former jobs include Senior Director-Corporate Licensing at Pharmacia, Inc., Principal at Bristol Myers Squibb Co., SVP-Business Development & Corporate Licensing at Sugen, Inc. from 1995 to 1999, SVP-Corporate Development & Commercial Operations at InterMune, Inc. from 2004 to 2007, Chief Business Officer at Melinta Subsidiary Corp., Vice President-Business Development at Corium LLC (Massachusetts) from 2010 to 2011, Chief Business Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. from 2016 to 2025, President at Dimension Therapeutics, Inc., and Senior Vice President-Corporate Development at Proteolix, Inc. from 2008 to 2009.
Education includes an undergraduate degree from Gustavus Adolphus College conferred in 1982 and an MBA from Kellogg School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-03-2025 | 264.730 ( 0,27% ) | 9 M $ | 30-06-2026 | |
PASSAGE BIO, INC. -.--% | 19-05-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PASSAGE BIO, INC. | Directeur/Bestuurslid | 10-09-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 22-09-2025 |
| CORIUM INTERNATIONAL INC | Corporate Officer/Principal | 01-10-2011 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Corporate Officer/Principal | 01-02-2009 |
| INTERMUNE INC | Corporate Officer/Principal | 03-07-2007 |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Oprichter | 01-07-2004 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 13 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Gustavus Adolphus College
Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Corium International, Inc.
Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Pharmacia, Inc. | |
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau